Status:
COMPLETED
Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
This study will investigate the safety and tolerability of the first IV dosing of SLV338 in healthy volunteers.
Eligibility Criteria
Inclusion
- healthy
Exclusion
- not healthy
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00885989
Start Date
May 1 2009
End Date
December 1 2009
Last Update
January 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 1
London, United Kingdom